1.480USD-2.95%Mkt Cap: 21.45M USDP/E: —Last update: 2026-06-01
CEL-SCI Corporation, a clinical-stage biotechnology company, engages in the research and development to treat cancer and other diseases by using the immune system in the United States. The company's lead immunotherapy is…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap21.45M USD
Enterprise Value19.18M USD
Revenue (TTM)—
Gross Profit-14.89M USD
Net Income (TTM)-25.41M USD
Revenue/Share—
Last Price1.480 USD
Fiscal Year EndSep 2025
MR QuarterMar 2026
Employees—
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.67
PEG1.12
EV/EBITDA-0.95
EV/Revenue—
P/S—
P/B1.90
EPS (TTM)-2.15
EPS (Forward)-0.92
52W Range
0.89005% of range13.48
52W High13.48 USD
52W Low0.8900 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-159.25%
ROA-90.25%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-17.12M USD
CapEx (TTM)38.11K USD
FCF Margin—
FCF Yield-43.03%
Net Debt6.61M USD
Net Debt/EBITDA-0.33
Balance Sheet
Debt/Equity0.59
Current Ratio0.60
Quick Ratio0.40
Book Value/Sh0.8090 USD
Cash/Share0.2240 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateAug 28, 1996
Pay DateJun 15, 2017
Splits
Last Split1:30
Split DateMay 20, 2025
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.14.49M
Float8.17M
Insiders5.46%
Institutions5.36%
Short Interest
Short Ratio0.4d
Short % Float1.77%
Short % Out.1.76%
Shares Short255.03K
Short (prev mo.)471.84K
Technical
SMA 502.871 (-48.5%)
SMA 2006.002 (-75.3%)
Beta0.71
S&P 52W Chg27.94%
Avg Vol (30d)653.93K
Avg Vol (10d)718.14K
Technical Indicators
RSI (14)37.7
MACD-0.4148
MACD Signal-0.4966
MACD Hist.+0.0818
BB Upper2.003 USD
BB Middle1.529 USD
BB Lower1.056 USD
BB Width61.95%
ATR (14)0.2649 USD
Vol Ratio (20d)0.20x